(Q48704908)

14 February 2018

title

Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1,000 studies (English)

1 reference

14 February 2018

0 references

Udupa JK

1

1 reference

14 February 2018

Nyúl LG

series ordinal

2

1 reference

14 February 2018

Ge Y

series ordinal

3

1 reference

14 February 2018

Grossman RI

series ordinal

4

1 reference

14 February 2018

publication date

1 November 2001

1 reference

14 February 2018

published in

Academic Radiology

1 reference

14 February 2018

volume

8

1 reference

14 February 2018

issue

11

1 reference

14 February 2018

page(s)

1116-1126

1 reference

14 February 2018

Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Nuclear magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images--lack of correlation between changes in T2 lesion volume and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Multiple sclerosis: gadolinium enhancement in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

The site of the lesion causing deafness in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE).

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Multiple sclerosis. Pathology of recurrent lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Fuzzy Connectedness and Object Definition: Theory, Algorithms, and Applications in Image Segmentation

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Multiple sclerosis lesion quantification using fuzzy-connectedness principles

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

A new computer-assisted method for the quantification of enhancing lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Isolated U-fiber involvement in MS: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

On standardizing the MR image intensity scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

New variants of a method of MRI scale standardization.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980723-7

7 January 2021

10.1016/S1076-6332(03)80723-7

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018